Search research articles
Contact Us
Filters
Showing results (221-230 of 259) with videos related to
Page
of 26
Sort By:
Cancer Discovery
|
May 6, 2022
Temozolomide Treatment Alters Mismatch Repair and Boosts Mutational Burden in Tumor and Blood of Colorectal Cancer Patients
Giovanni Crisafulli, Andrea Sartore-Bianchi, Luca Lazzari, et al.
Clinical Colorectal Cancer
|
September 13, 2020
Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer
Federica Tosi, Andrea Sartore-Bianchi, Sara Lonardi, et al.
Science Translational Medicine
|
May 21, 2025
Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancer
Elena Grassi, Valentina Vurchio, George D Cresswell, et al.
Journal of the National Cancer Institute
|
April 7, 2021
EGFR Amplification in Metastatic Colorectal Cancer
Giovanni Randon, Rona Yaeger, Jaclyn F Hechtman, et al.
Cancer Discovery
|
April 21, 2026
Pharmacological inhibition of PMS2 induces MMR deficiency and response to immune checkpoint blockade
Julian Blagg, Philippe Riou, Alexia Hervieu, et al.
Gut
|
October 7, 2017
Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer
Ludovic Barault, Alessio Amatu, Giulia Siravegna, et al.
Nature Medicine
|
August 7, 2015
Toward understanding and exploiting tumor heterogeneity
Ash A Alizadeh, Victoria Aranda, Alberto Bardelli, et al.
Cancer Discovery
|
June 5, 2013
Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer
Alberto Bardelli, Simona Corso, Andrea Bertotti, et al.
BJC Reports
|
March 27, 2025
A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancers
Peter Gallagher, Christian Rolfo, Elena Elez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 13, 2018
Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade
Giuseppe Lo Russo, Massimo Moro, Michele Sommariva, et al.
Page
of 26
Search research articles
Search
Showing results (221-230 of 259) with videos related to
Sort By:
Page
of 26
Cancer Discovery
|
May 6, 2022
Temozolomide Treatment Alters Mismatch Repair and Boosts Mutational Burden in Tumor and Blood of Colorectal Cancer Patients
Giovanni Crisafulli, Andrea Sartore-Bianchi, Luca Lazzari, et al.
Clinical Colorectal Cancer
|
September 13, 2020
Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer
Federica Tosi, Andrea Sartore-Bianchi, Sara Lonardi, et al.
Science Translational Medicine
|
May 21, 2025
Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancer
Elena Grassi, Valentina Vurchio, George D Cresswell, et al.
Journal of the National Cancer Institute
|
April 7, 2021
EGFR Amplification in Metastatic Colorectal Cancer
Giovanni Randon, Rona Yaeger, Jaclyn F Hechtman, et al.
Cancer Discovery
|
April 21, 2026
Pharmacological inhibition of PMS2 induces MMR deficiency and response to immune checkpoint blockade
Julian Blagg, Philippe Riou, Alexia Hervieu, et al.
Gut
|
October 7, 2017
Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer
Ludovic Barault, Alessio Amatu, Giulia Siravegna, et al.
Nature Medicine
|
August 7, 2015
Toward understanding and exploiting tumor heterogeneity
Ash A Alizadeh, Victoria Aranda, Alberto Bardelli, et al.
Cancer Discovery
|
June 5, 2013
Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer
Alberto Bardelli, Simona Corso, Andrea Bertotti, et al.
BJC Reports
|
March 27, 2025
A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancers
Peter Gallagher, Christian Rolfo, Elena Elez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 13, 2018
Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade
Giuseppe Lo Russo, Massimo Moro, Michele Sommariva, et al.
Page
of 26